We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

300454:SZSESangfor Technologies, Inc. Class A Analysis

Data as of 2026-06-26 - not real-time

CN¥89.30

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Sangfor Technologies is trading well below its 200‑day moving average, with the 20‑day SMA sitting beneath the 50‑day SMA, indicating a bearish price structure. The MACD histogram is negative and the RSI is in the low‑30s, suggesting momentum weakness and potential oversold conditions. Valuation metrics such as a price‑to‑earnings multiple far above the industry average and a discounted cash‑flow fair value well under the current market price point to an overvalued market stance. Revenue growth remains robust, driven by strong demand for cloud and security solutions, yet operating margins are negative and free cash flow is in deficit, highlighting profitability challenges.
Dividend policy is modest with a very low payout ratio, which coupled with a solid cash balance and minimal debt, supports dividend sustainability. The company faces elevated sector and regulatory headwinds typical of Chinese technology firms, while its beta suggests limited systematic risk. Liquidity appears moderate as trading volumes have been on a downtrend despite a sizable market cap. Overall, the stock presents a mixed picture of growth potential tempered by valuation pressure and heightened risk factors.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish technical indicators (negative MACD, low RSI)
  • Current price near recent support level
  • Overvaluation relative to DCF and peers

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong revenue growth trajectory
  • Improving forward earnings expectations
  • Continued pressure from high valuation multiples

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strategic positioning in cloud and cybersecurity markets
  • Sustainable dividend despite low yield
  • Persisting regulatory and sector volatility in China

Key Metrics & Analysis

Financial Health

Revenue Growth28.90%
Profit Margin6.87%
P/E Ratio66.6
ROE5.82%
ROA1.01%
Debt/Equity0.68
P/B Ratio3.5
Op. Cash FlowCN¥993.4M
Free Cash FlowCN¥-783306752
Industry P/E36.8

Technical Analysis

TrendBearish
RSI31.5
SupportCN¥89.21
ResistanceCN¥125.88
MA 20CN¥103.59
MA 50CN¥111.43
MA 200CN¥119.38
MACDBearish
VolumeDecreasing
Fear & Greed Index85.48

Valuation

Fair ValueCN¥61.39
Target PriceCN¥132.68
Upside/Downside48.58%
GradeOvervalued
TypeGrowth
Dividend Yield0.11%

Risk Assessment

Beta0.55
Volatility57.92%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.